Frequently expressed glypican-3 as a promising novel therapeutic target for osteosarcomas.
Cancer Sci
; 113(10): 3618-3632, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-35946078
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bone Neoplasms
/
Osteosarcoma
/
Carcinoma, Hepatocellular
/
Liver Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Cancer Sci
Year:
2022
Document type:
Article
Affiliation country:
China